Mirae Asset Global ETFs Holdings
NKTR icon

Mirae Asset Global ETFs Holdings’s Nektar Therapeutics NKTR Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Buy
+15,805
New +$1.16M ﹤0.01% 1592
2025
Q2 		– Sell
-7,126
Closed -$72.7K – 3160
2025
Q1 		$72.7K Buy
7,126
+302
+4% +$3.95K ﹤0.01% 2753
2024
Q4 		$95.2K Buy
6,824
+294
+5% +$5.18K ﹤0.01% 2718
2024
Q3 		$127K Buy
+6,530
New +$124K ﹤0.01% 2588

Other funds holding NKTR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's NKTR Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Nektar Therapeutics (NKTR) in Q2 2026: 15,805 shares worth $1.1M. The stake represents ﹤0.01% of the portfolio and ranks #1592 among its holdings. This is a return to the name: Mirae Asset Global ETFs Holdings previously reported a position in NKTR as recently as Q1 2025.

Mirae Asset Global ETFs Holdings first reported a position in NKTR in Q3 2024 and has held it in 4 quarters since. 239 funds tracked by Wall St. Rank hold NKTR as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 15,805 shares of Nektar Therapeutics worth $1.1M as of Q2 2026.
  • Nektar Therapeutics was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
  • Nektar Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1592 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Nektar Therapeutics in Q3 2024 and has held it in 4 quarters since.
  • 239 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.